IL-4 alone without the involvement of GM-CSF transforms human peripheral blood monocytes to a CD1adim, CD83+ myeloid dendritic cell subset
Open Access
- 15 July 2004
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 117 (16) , 3435-3445
- https://doi.org/10.1242/jcs.01162
Abstract
Myeloid dendritic cells (DCs) are conventionally generated by culturing human peripheral blood monocytes in the presence of GM-CSF and IL-4. Here we report that IL-4 alone, in the absence of detectable endogenous GM-CSF, transforms human peripheral blood monocytes to a CD1adim DC subset that could be matured to CD83+ DCs. Absence of endogenous GM-CSF in IL-4-DC was demonstrated by RT-PCR and flow cytometry. With the exception of CD1a expression, surface marker, morphology and phagocytic activity of these DCs (IL-4-DC) were similar to myeloid DCs (GM-IL-4-DC) conventionally generated in the presence of GM-CSF and IL-4. Conventional GM-IL-4-DC produced less IL-12 compared with IL-4-DC after stimulation with anti-CD40 monoclonal antibody, or LPS plus IFN-γ, although the difference was more prominent when LPS plus IFN-γ was used as the stimulus. The GM-IL-4-DC also induced less frequent IFN-γ+ T cells in a mixed leukocyte reaction (MLR) than that of IL-4-DC. Yields of IL-4-DCs were marginally lower than that of GM-IL-4-DCs. Our data indicate that peripheral blood monocytes can be transformed to CD1a-deficient myeloid DCs solely by IL-4, and these IL-4-DCs are likely to induce a stronger Th1 response than conventional GM-IL-4-DCs.Keywords
This publication has 42 references indexed in Scilit:
- Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial AntigensThe Journal of Experimental Medicine, 2001
- The Common Vaccine Adjuvant Aluminum Hydroxide Up-Regulates Accessory Properties of Human Monocytes via an Interleukin-4-Dependent MechanismInfection and Immunity, 2001
- Interleukin‐4 inhibits granulocyte‐macrophage colony‐stimulating factor, interleukin‐6, and tumor necrosis factor‐alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitroJournal of Orthopaedic Research, 1999
- Inhibition of GM-CSF Production by Recombinant Human Interleukin-4: Negative Regulator of HematopoiesisLeukemia & Lymphoma, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Recombinant human interleukin-4 inhibits the production of granulocyte-macrophage colony stimulating factor by blood mononuclear cellsBritish Journal of Haematology, 1994
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Interleukin 4 down‐regulates the expression of CD14 in normal human monocytesEuropean Journal of Immunology, 1990
- Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cellsCellular Immunology, 1988
- Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.The Journal of Experimental Medicine, 1986